Billiontoone (NASDAQ:BLLN) CTO David Tsao Sells 20,000 Shares of Company Stock

Key Points

• CTO David Tsao sold 20,000 Billiontoone shares at an average price of $108.15, generating $2.16 million. The Rule 10b5-1 transaction reduced his direct holdings by 95.24%, to 1,000 shares.
• Billiontoone shares fell 4.2% to $95.75, giving the company a market capitalization of approximately $4.52 billion. The stock remains well below its 52-week high of $150.44.
• Analysts maintain a generally positive outlook, with a consensus “Moderate Buy” rating and an average price target of $126.25, despite several recent target-price cuts.

Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report) CTO David Tsao sold 20,000 shares of the firm's stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $108.15, for a total transaction of $2,163,000.00. Following the completion of the transaction, the chief technology officer directly owned 1,000 shares of the company's stock, valued at $108,150. This represents a 95.24% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Tsao also recently made the following trade(s):

• On Thursday, September 24th, David Tsao sold 3,333 shares of Billiontoone stock. The shares were sold at an average price of $125.00, for a total transaction of $416,625.00.
• On Wednesday, September 9th, David Tsao sold 20,000 shares of Billiontoone stock. The shares were sold at an average price of $98.77, for a total value of $1,975,400.00.
• On Tuesday, August 25th, David Tsao sold 10,000 shares of Billiontoone stock. The shares were sold at an average price of $100.00, for a total value of $1,000,000.00.
• On Monday, August 10th, David Tsao sold 10,000 shares of Billiontoone stock. The shares were sold at an average price of $92.86, for a total value of $928,600.00.

Billiontoone Stock Down 4.2%

Billiontoone stock traded down $4.19 during mid-day trading on Wednesday, hitting $95.75. The company's stock had a trading volume of 679,799 shares, compared to its average volume of 656,006. The firm's 50 day moving average is $105.26 and its 200 day moving average is $100.66. The company has a market cap of $4.52 billion and a PE ratio of 142.77. The company has a debt-to-equity ratio of 0.17, a current ratio of 11.69 and a quick ratio of 11.31. Billiontoone, Inc. has a 52-week low of $61.96 and a 52-week high of $150.44.

Billiontoone (NASDAQ:BLLN - Get Free Report) last released its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share for the quarter, meeting the consensus estimate of $0.15. The company had revenue of $109.45 million for the quarter. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. On average, analysts anticipate that Billiontoone, Inc. will post 0.83 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts have issued reports on the stock. BTIG Research cut their target price on shares of Billiontoone from $142.00 to $130.00 and set a "buy" rating for the company in a research report on Thursday, August 6th. Zacks Research raised shares of Billiontoone from a "strong sell" rating to a "hold" rating in a research note on Friday, October 2nd. JPMorgan Chase & Co. cut their price objective on Billiontoone from $145.00 to $130.00 and set an "overweight" rating for the company in a report on Thursday, August 6th. Guggenheim lifted their price objective on Billiontoone from $125.00 to $128.00 and gave the company a "buy" rating in a research report on Thursday, October 1st. Finally, Wall Street Zen downgraded Billiontoone from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. Seven analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, Billiontoone presently has an average rating of "Moderate Buy" and a consensus price target of $126.25.

Hedge Funds Weigh In On Billiontoone

A number of institutional investors have recently modified their holdings of the company. Integrated Wealth Concepts LLC acquired a new stake in shares of Billiontoone in the second quarter worth $29,000. MCF Advisors LLC grew its stake in Billiontoone by 330.8% in the 2nd quarter. MCF Advisors LLC now owns 448 shares of the company's stock valued at $54,000 after buying an additional 344 shares during the last quarter. Family Legacy Financial Solutions LLC bought a new position in Billiontoone in the 3rd quarter worth $53,000. Thrive Wealth Management LLC bought a new position in Billiontoone in the 2nd quarter worth $240,000. Finally, Caitong International Asset Management Co. Ltd acquired a new position in Billiontoone during the 4th quarter worth $230,000.

About Billiontoone

BillionToOne, Inc NASDAQ: BLLN is a molecular diagnostics company that develops blood-based genetic tests designed to provide more information from small amounts of cell-free DNA. The company's platform uses proprietary molecular counting technology to improve the sensitivity and accuracy of diagnostic testing.

BillionToOne's primary business is reproductive health testing. Its UNITY portfolio is designed to support prenatal screening, including testing for chromosomal conditions and single-gene disorders, and is intended to provide physicians and expectant parents with information from a maternal blood sample.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.